RASopathy-Associated Cardiac Hypertrophy: A Shocking Gap in Care.

Ackerman, Michael J; Garmany, Ramin

RASopathy-Associated Cardiac Hypertrophy: A Shocking Gap in Care.

Ackerman, Michael J; Garmany, Ramin.

Afiliación

Ackerman MJ; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA; Department of Pediatric and Adolescent Medicine/Division of Pediatric Cardiology, Windland Smith Rice Genetic Heart Rhythm Clinic, Mayo Clinic, Rochester, Minnesota, USA; Department of Molecular Pharmacology & Experimental Therapeutics, Windland Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: ackerman.michael@mayo.edu.
Garmany R; Department of Molecular Pharmacology & Experimental Therapeutics, Windland Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, Minnesota, USA; Mayo Clinic Medical Scientist Training Program, Rochester, Minnesota, USA. Electronic address: https://twitter.com/GarmanyRamin.

J Am Coll Cardiol ; 81(11): 1046-1048, 2023 03 21.

Article en En | MEDLINE | ID: mdl-36922090

Asunto(s)

Muerte Súbita Cardíaca; Desfibriladores Implantables; Humanos; Cardiomegalia

Palabras clave

RASopathy; implantable cardioverter-defibrillator; shared decision making; sudden death

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Muerte Súbita Cardíaca / Desfibriladores Implantables Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: J Am Coll Cardiol Año: 2023 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google